Printer Friendly
The Free Library
14,716,216 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for Procept, dated Aug. 9, 1996.


--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. .

These include Dow Jones Dow Jones

the best known of several U.S. indexes of movements in price on Wall Street. [Am. Hist.: Payton, 202]

See : Finance
 News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine See AOL. , CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International
UMI United States Minor Outlying Islands (ISO Country code)
UMI University of Miami
UMI Universal Management Infrastructure (IBM) 
 Data Courier, NewsBank, Information Access Company, Prodigy, Comtex, and many others. -0-

Published Date:   Aug. 9, 1996


Company Name:     Procept Inc.


Address:          840 Memorial Drive
                  Cambridge, Mass.  02139


Main Telephone
 Number:          617/491-1100


Chief Executive
 Officer:         Stanley C. Erck


Investor Relations
 Contact:         Michael J. Higgins
 Business number: 617/491-1100 x3255


Public Relations
 Contact:         Michael J. Higgins
 Business number: 617/491-1100 x3255


URL Address:      www.procept.com


Trading Symbol:   PRCT


Industry:         pharmaceutical, biotechnology




Company description: Procept Inc. is engaged in the research and development of small molecule therapeutics for the prevention and treatment of chronic and life-threatening immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 disorders. The company's research is based upon its understanding of critical cell receptors responsible for modulating immune responses, combined with the drug discovery technologies of rational drug design and combinatorial chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction
Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules.
. Procept is developing therapeutics for the treatment of arthritis, diabetes, organ transplant rejection and infectious diseases, including AIDS and tuberculosis. Founded in 1985 and traded on the Nasdaq National Market System under the symbol PRCT PRCT Practice
PRCT Prospective, Randomized, Controlled Trial (medicine)
PRCT Partial Rotator Cuff Tear
, Procept is located in Cambridge, Mass.

CONTACT: Procept Inc.
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 9, 1996
Words:238
Previous Article:Corporate Profile for Bristol Hotel Company, dated Aug. 9, 1996.
Next Article:Corporate Profile for InfoPartners, Inc., dated Aug. 9, 1996.
Topics:



Related Articles
PROCEPT AND BRISTOL-MYERS SQUIBB COMPLETE COLLABORATION AGREEMENT.
Procept, Inc. Completes Phase I Safety Trial of PRO 2000 for the Treatment of HIV-1 Infection.
Procept Begins Phase I/II Clinical Trial for PRO 2000 in HIV-Positive Patients; Company-sponsored trial will evaluate activity of lead HIV...
Sandoz And Procept Agree To Continue Research Partnership; Procept To Receive $2.2 Million Payment.
PROCEPT ANNOUNCES FIRST QUARTER FINANCIAL RESULTS.
Procept announces second quarter financial results.
Procept names director of financial reporting.
Procept announces restructuring; Focus on clinical drug candidates, corporate partnering programs.
Corporate Profile for Procept, dated May 23, 1997.
Antiviral gel clears safety test. (intravaginal gel that kills HIV appears safe in test in women)(Brief Article)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles